Synnovation launches with $102m to advance therapy pipeline

Synnovation Therapeutics has launched with a $102m Series A financing to progress the development its pipeline of targeted therapies.

Related Posts

Myrtelle gets ILAP status from UK for Canavan disease t...

Apr 26, 2023

Listen: 2023 in review, CEO report cards, and a look at...

Dec 21, 2023

Moderna to set up new mRNA manufacturing facility in Kenya

Mar 31, 2023